CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in PRAX — Praxis Precision Medicines, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in PRAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$73,656,478
+$4,241,610 QoQ
Shares Held
220,008
+2.1% QoQ
Ownership
0.788%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#30
of 308 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. PRAX ranks #24 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in PRAX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,656,478 | 220,008 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $69,414,868 | 215,447 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $58,447,236 | 198,301 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,568,033 | 161,661 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,410,270 | 152,444 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,342,699 | 141,080 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $10,996,968 | 142,892 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $7,885,972 | 137,052 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,963,524 | 47,474 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $408,162 | 6,689 | Shares | Sole | 2024-05-09 | |
| 2023-09-30 | $36,169 | 21,152 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $24,324 | 21,152 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $104,600 | 129,296 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $262,663 | 110,363 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $191,099 | 84,185 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $632,874 | 258,316 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,595,126 | 254,175 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,880,891 | 247,761 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,399,048 | 237,915 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $2,188,463 | 119,719 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,379,948 | 72,648 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $3,838,195 | 69,760 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||